Avance Clinical

Avance Clinical, established in 2019, is a prominent global contract research organization (CRO) specializing in comprehensive clinical trial services for biotechnology and pharmaceutical companies. Operating across 3 locations, the firm is dedicated to advancing drug development pipelines, supporting clients from early preclinical research through to late-stage clinical studies. Their core mission involves accelerating the journey of novel therapeutics to market by providing end-to-end solutions. The company leverages its expertise to navigate the complexities of drug discovery and development, ensuring efficient progression for its partners.

The organization offers deep expertise in critical areas such as sophisticated trial management, rigorous data analysis, stringent regulatory compliance, and effective patient recruitment strategies. With an employee base ranging from 500 - 1,000 employees, Avance Clinical is equipped to handle diverse project scopes. Their financial performance is notable, with a reported revenue of $105.7M. For insights into their operational structure and leadership, one can explore Meet Avance Clinical's team. This team's collective experience is instrumental in delivering successful outcomes for complex clinical research projects.

Positioned within the Business Services sector, Avance Clinical competes with established players like Novotech and Mayne Pharma. Their services are crucial for companies seeking to optimize their clinical research efforts, particularly within the Australian and broader Asia-Pacific regions, as indicated by their headquarters in Adelaide, South Australia. The company's focus on delivering high-quality, data-driven results underscores its commitment to innovation and client success in the pharmaceutical and biotech industries.